GlassScriptPhysician profile
Laura Binkley
NPI 1942419239
$12,204.75
in general payments reported to CMS, 2019-2025
15 companies · $6,215 in 2025
The $6,215 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $106 · 2023: $35.47 · 2024: $5,614 · 2025: $6,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $64.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,800.00 |
| Food and Beverage | $64.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $11,800.00 | 2024-2025 | Bovine Collagen |
| Avion Pharmaceuticals | $63.65 | 2019-2020 | |
| Allergan, INC. | $52.64 | 2019-2020 | |
| Coopersurgical, INC. | $40.69 | 2019-2025 | Sos |
| Abbvie INC. | $36.74 | 2019-2020 | |
| Hologic Sales and Service, LLC | $36.72 | 2020-2023 | Aptima |
| Pfizer INC. | $31.61 | 2023-2024 | |
| Exeltis, USA INC. | $27.45 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $23.18 | 2019-2020 | |
| Olympus America INC. | $20.57 | 2019 | |
| Duchesnay USA Incorporated | $18.45 | 2019 | |
| Daiichi Sankyo INC. | $17.91 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.38 | 2019 | |
| Merck Sharp & Dohme LLC | $13.46 | 2019 | |
| Bolder Surgical LLC | $7.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Binkley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.